Related Experiment Video

Updated: Jun 6, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

α-TEA cooperates with MEK or mTOR inhibitors to induce apoptosis via targeting IRS/PI3K pathways

R Tiwary1, W Yu, B G Sanders

  • 1School of Biological Sciences/C0900, University of Texas, 1 University Station, Austin, TX 78712, USA.

British Journal of Cancer
|December 2, 2010
PubMed
Abstract

Insights

α-Tocopherol ether-linked acetic acid (α-TEA) induces apoptosis in human breast cancer cells by inhibiting the IRS-1/PI3K pathway. This mechanism involves JNK activation and downregulation of AKT, ERK, and mTOR signaling, offering a new therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • α-Tocopherol ether-linked acetic acid (α-TEA) exhibits promising anti-tumor properties across various cancers.
  • Its therapeutic potential in cancer prevention and treatment warrants further investigation.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying the anti-cancer effects of α-TEA in human breast cancer cells.
  • To investigate the role of specific signaling pathways, including PI3K/AKT, ERK, and mTOR, in α-TEA-mediated apoptosis.

Main Methods:

  • Utilized human breast cancer cell lines (MCF-7 and HCC-1954).
  • Employed Annexin V/PI staining for apoptosis assessment.
  • Performed Western blot analyses and siRNA knockdown techniques to study protein expression and pathway modulation.

Main Results:

  • α-TEA suppressed basal levels of pAKT, pERK, and pmTOR, leading to apoptosis.
  • Inhibition of Phosphoinositide 3-kinase (PI3K) confirmed its role as an upstream mediator.
  • α-TEA increased pIRS-1 (Ser-307) and decreased total IRS-1, with JNK knockdown blocking these effects.
  • Combinations of α-TEA with MEK or mTOR inhibitors enhanced apoptosis and modulated signaling pathways.

Conclusions:

  • Downregulation of the IRS-1/PI3K pathway via JNK is crucial for α-TEA-induced apoptosis.
  • α-TEA, alone or in combination with MEK/mTOR inhibitors, demonstrates significant anti-cancer activity in breast cancer cells.
  • These findings highlight a novel therapeutic strategy targeting the IRS-1/PI3K/JNK axis for breast cancer treatment.

More Related Videos

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers10:49

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers

Published on: September 26, 2019

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...